Dedicated to the prevention & treatment of chronic inflammatory conditions
Chronic inflammation contributes to many of the largest and most serious conditions impacting our health today
It is estimated that in the United States alone half the population is affected by diseases associated with chronic inflammation. These conditions include heart disease, diabetes, arthritis, digestive disorders, asthma, allergies, eczema, psoriasis and many others.
Through our Gene Smart Nutrigenomics Discovery Platform, we examine the influence of natural bioactives on the expression of genes that control the inflammatory process. Utilizing this technology, we are developing a robust pipeline of patent-protected products for the prevention and treatment of targeted chronic inflammatory disorders in humans and animals. These products are designed for the Over-the-Counter (OTC), Functional Food & Beverage, and Veterinary Medical Food markets.
Our product platforms are brought to the U.S. and global markets through strategic partnerships with market leaders seeking to establish major new growth platforms.
Our first product was an OTC medical food for the dietary management of asthma based on a proprietary combination of natural fatty acids. We developed and tested the product through five clinical trials to validate safety and efficacy, and licensed it to Efficas, a Colorado-based consumer focused health-science and technology company (www.efficas.com).
News 
Market Data 
Discover 
AI
